Evidence map›Paper›PMID 35056144›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Extraction and Fractionation of Bioactives from

Piret Saar-Reismaa, Olga Bragina, Maria Kuhtinskaja, Indrek Reile, Pille-Riin Laanet, Maria Kulp, Merike Vaher

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Characterization ofPlants (Basel, Switzerland) · 2026
    Article
  2. Molecules (Basel, Switzerland) · 2024
    Review
  3. International journal of molecular sciences · 2024
    Article
  4. Molecules (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Piret Saar-ReismaaDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.ORCID 0000-0003-3489-4797
Olga BraginaDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.
Maria KuhtinskajaDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.
Indrek ReileNational Institute of Chemical Physics and Biophysics, 12618 Tallinn, Estonia.ORCID 0000-0003-3278-7947
Pille-Riin LaanetDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.ORCID 0000-0002-2276-2925
Maria KulpDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.
Merike VaherDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.ORCID 0000-0002-3818-1906
Tallinn University of Technology · EENational Institute of Chemical Physics and Biophysics · EE

Funding

Archimedes Foundation Development of additional analytical capabilities for Estonian Center of Analytical Chemistry, AKKIArchimedes Foundation TK-134Estonian Research Council PSG11
6 · The paper itself

Abstract

Lyme disease (LD) is a tick-borne bacterial disease that is caused by

Indexed as

antibacterial activitybis-iridoidsBorrelia burgdorfericytotoxicityDipsacus fullonum L.sylvestrosides

Identifiers

PMID35056144
PMCPMC8779505
OpenAlexW4206678494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.